Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients

International Journal of Clinical Practice

Volumn 63, Issue 3, 2009, Pages 394-397

  Ramezani, A ^a   Eslamifar, A ^a   Banifazl, M ^b   Ahmadi, F ^c   Maziar, S ^c   Razeghi, E ^c   Kalantar, E ^d   Amirkhani, A ^a   Aghakhani, A ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Iranian Society for Support of Patients with Infectious Diseases   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEBERBIOVAC; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELTOID MUSCLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; YOUNG ADULT;

EID: 59349087903     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01470.x     Document Type: Article

References (18)

1. Brown J, Peters V. Improved hepatitis B vaccination rates in ESRD patients in California. Adv Ren Replace Ther 2000 7 : 95 9.
2. Plotkin SA, Orenstein WA, eds. Vaccines, 4th edn. Philadelphia : WB Saunders, 2004 317.
3. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000 36 : 976 82.
4. Sezer S, Ozdemir FN, Guz G et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc 2000 32 : 607 8.
5. Fernandez E, Betriu MA, Gomrez R, Montoliu J. Response to the hepatitis B virus vaccine in hemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996 11 : 1559 63.
6. Paynter HE, Clarke J, McArley A, Williams AJ. Hepatitis B vaccination. Nephrol Dial Transplant 1997 12 : 623 4.
7. McDermott AB, Zuckerman JN, Sabin CA et al. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997 50 : 8 14.
8. Kovacic V, Saint M, Vukman V. Does efficient haemodialysis improve the response to hepatitis B virus vaccination Lijec Vjesn 2004 126 : 133 7.
9. Shatat HZ, Kotkat AM, Farghaly AG. Immune response to hepatitis B vaccine in haemodialysis patients. J Egypt Public Health Assoc 2000 75 : 257 75.
10. Buti M, Viladomiu L, Jardi R et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992 12 : 144 7.
11. Kausz A, Pahari D. The value of vaccination in chronic kidney disease. Semin Dial 2004 17 : 9 11.
12. Peces R, de la Torre M, Alcazar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in haemodialysis patients. Am J Kidney Dis 1997 29 : 239 45.
13. Chin AI. Hepatitis B virus vaccine response in hemodialysis: baseline patient characteristics. Hemodial Int 2003 7 : 296 303.
14. Urbanowicz W. Efficacy of prophylactic vaccination against hepatitis B virus infection viruses in hemodialyzed patients. Przegl Epidemiol 2000 54 : 343 50.
15. Navarro JF, Teruel JL, Mateos M, Ortuno J. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994 41 : 113 6.
16. Stachowski J, Kramer J, Fust G et al. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in hemodialysis patients. Scand J Immunol 1995 42 : 60 5.
17. Kacprzak-Bergman I, Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch Immunol Ther Exp 2005 53 : 139 42.
18. Fabrizi F, Di Filippo S, Marcelli D et al. Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis. Nephron 1996 72 : 536 43.